Back to KROS
MARSHALL WACE, LLP KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
3
Latest value
$1.3M
Q3 2026
Peak value
$1.3M
First seen
Q2 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2026 | $370K |
| Q3 2026 | $59K |
| Q3 2026 | $1.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.3M | 110.6K | — | — |
| Q3 2026 | $59K | 5.2K | — | — |
| Q2 2026 | $370K | 34.6K | — | — |